Apoptosis and antiphospholipid antibodies

Seminars in Arthritis and Rheumatism

Volumn 28, Issue 3, 1998, Pages 163-178

  Pittoni, V ^a   Isenberg, D ^a  

^a Centre for Rheumatology   (United Kingdom)

Author keywords

Apoptosis; Autoantibodies; Phospholipid

Indexed keywords

BETA2 GLYCOPROTEIN 1; CARRIER PROTEIN; FAS ANTIGEN; LIPOCORTIN 5; PHOSPHOLIPID; PHOSPHOLIPID ANTIBODY; PROCOAGULANT; PROTEIN BCL 2; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA;

ANTIPHOSPHOLIPID SYNDROME; APOPTOSIS; HUMAN; NONHUMAN; PATHOGENESIS; PHOSPHOLIPID MEMBRANE; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; REVIEW;

EID: 0031701869     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-0172(98)80033-4     Document Type: Article

References (149)

1. Harris E.N. A reassesment of the antiphospholipid syndrome J Rheumatol 17 1990 733 735
2. Levy R.A. Clinical manifestations of the aPL syndrome Lupus 5 1996 393 397
3. Oosting J.D. Derksen R.H.W.M. Bobbink I.W.G. Hackeugt T.M. Bouma B.N. De Groot P.G. Antiphospholipid antibodies directed against a combination of phospholipids with prothrombin, protein C and protein S: an explanation for theirpathogenic mechanism? Blood 81 1993 2618 2625
4. McNeil H.P. Simpson R.J. Chesterman C.N. Krilis S.A. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid binding inhibitor of coagulation: beta2-glycoprotein I(apolipoprotein H) Proc Natl Acad Sci U S A 87 1990 4120 4124
5. Amengual O. Atsumi T. Khamashta M.A. Koike T. Hughes G.R.V. Specificity of ELISA for antibody to β2-glycoprotein I in patients with antiphospholipid syndrome Br J Rheumatol 35 1996 1239 1243
6. Sorice M. Griggi T. Circella A. Detection of antiphospholipid antibodies by immunostaining on thin layer chromatography plates J Immunol Methods 173 1994 49 54
7. Roubey R.A.S. Eisenberg R. Harper M.F. Winfield J.B. “Amicardiolipin” antibodies recognize β2-glycoprotein I in the absence of phospholipid: importance of ag density and bivalent binding J Immunol 154 1995 954 960
8. Pengo V. Basiolo A. Fior M.G. Autoimmune antiphospholipid antibodies are directed against a cryptic epitope expressed when β2-glycoprotein I is bound to a suitable surface Thromb Haemost 73 1995 29 34
9. Casciola-Rosen L. Rosen A. Petri M. Schlissel M. Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implication for coagulation events and antigenic spread in systemiclupus erythematosus Proc Natl Acad Sci U S A 93 1996 1624 1629
10. Osborne B.A. Apoptosis and the maintenance of homeostasis in the immune system Curr Opin Immunol 8 1996 245 254
11. Evan G.I. Old cells never die, they just apoptose Trends Cell Biol 4 1994 191 192
12. Hale A.J. Smith C.A. Sutherland L.C. Stoneman V.E. Longthorne V. Culhane A.C. Apoptosis: molecular regulation of cell death Eur J Biochem 237 1996 884
13. Thomas N. Bell P.A. Glucocorticoid induced cell size changes and nuclear fragility in rat thymocytes Mol Cell Endocrinol 22 1981 41 84
14. Ohyama H. Yamada T. Watabane I. Cell volume reduction associated with interphase death in rat thymocytes Radiat Res 85 1981 333 339
15. Godman G.C. Miranda A.F. Deitch A.D. Tanenbaum S.W. Action of cytochalasin D on cells of established lines: zeiosis and movement of cell surface J Cell Biol 64 1975 644 667
16. Fadok V. Voelker D.R. Campbell P.A. Cohen J.J. Bratton D.L. Henson P.M. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages J Immunol 148 1992 2207 2216
17. Lynch D.A. Ramsdell F. Alderson M.R. Fas and FasL in the homeostatic regulation of immune responses Immunol Today 16 1995 569 574
18. Nunez G. Merino R. Grillot D. Gonzales Garcia M. Bcl-2 and Bcl-x: regulatory switches for lymphoid death and survival Immunol Today 15 1994 582 588
19. Smith C.A. Williams G.T. Kingston R. Jenkinson E.J. Owen J.T. Antibodies to CD3/T cell receptor complex induce death by apoptosis in immature T cells in thymic cultures Nature 337 1989 181 184
20. Osmond D.G. Rico-Vargas S. Valenzona H. Fauteux L. Janari R. Jacobsen L.K. Apoptosis and macrophage-mediated cell deletion in the regulation of B lymphopoiesis in mouse bone marrow Immunol Rew 142 1994 209 230
21. Lenardo M.J. Boeheme S. Chen L. Autocrine feedback death and the regulation of mature T lymphocyte antigen responses Int Rev Immunol 13 1995 115 134
22. Akbar A.N. Salmon N. Cellular environment and apoptosis: tissue microenvironments control activated T-cell death Immunol Today 18 1997 72 76
23. Basten A. Brink R. Peake P. Self-tolerance in the B-cell repertoir Immunol Rev 122 1991 5 19
24. Pulendran B. Van Driel Nossal G.J.V. Immunological tolerance in germinal centres Immunol Today 18 1997 27 32
25. Mower D.A. Peckman D.W. Illera V.A. Fishbaugh J.K. Stunz L.L. Ashman R.E. Decreased membrane phospholipid packing and decreased cell size precede DNA cleavage in mature mouse B cell apoptosis J Immunol 152 1994 4832 4842
26. Devaux F.P. Zachowski A. Maintenance and consequences of membrane phospholipid asymmetry Chem Phys Lipids 73 1994 107 120
27. Williamson P. Schlegel R.A. Back and forth: the regulation and function of transbilayer phospholipid movement in eukaryotic cells Mol Membrane Biol 11 1994 199 216
28. Schroit A.J. Zwaal R.F.A. Transbilayer movement of phospbolipids in red cells and platelet membranes Biochim Biophys Acta 1071 1991 313 329
29. Connor J. Pack C.H. Zwaal R.F.A. Schroit A.J. Bidirectional transbilayer movement of phospholipid analogs in human red blood cells J Biol Chem 267 1992 19412 19417
30. Haest C.V.M. Deutike B. Possible relationship between membrane proteins and phospholipid asymmetry in human erythrocyte membranes Biochim Biophys Acta 436 1976 353 365
31. Stuart M.C.A. Bevers E.M. Confurius P. Zwaal R.F.A. Reuteligsperger C.P.M. Frederik P.M. Ultrastructural detection of surface exposed phosphatidylserine on activated blood platelets Thromb Haemost 74 1995 1145 1151
32. Confurius P. Smeets E.F. Schlegel R.A. Bevers E.M. Zwaal R.E. Reconstitution of phospholipid scramblase activity from human blood platelets Biochemistry 35 1996 7631 7634
33. 2+ induces transbilayer redistribution of all major phosppbolipids in human erythrocytes Biochemistry 31 1992 6355 6360
34. Bevers E.M. Confurius P. Zwaal R.F.A. Regulatory mechanisms in maintenance and modulation of transmembrane lipid asymmetry: pathophysiological implications Lupus 5 1996 480 487
35. 2+-ATPase inhibitors Biochemistry 34 1995 11625 11634
36. Zwaal F.A. Schroit A.J. Pathophysiological implication of membrane phospholipid asymmetry in blood cells Blood 89 1997 1121 1132
37. Verhoven B. Schlegel R.A. Williamson P. Mechanism of phosphaddylserine exposure, a phagocyte recognition signal on apoptotic T lymphocytes J Exp Med 182 1995 1597 1601
38. Zazami N. Susin S.A. Marchetti P. Mitochondrial control of nuclear apoptosis J Exp Med 183 1996 1533 1544
39. Menon S.H. Rahman M.A.A. Ravirajan C.T. The production, binding characteristic and sequence analysis of four human IgG monoclonal antiphospholipid antibodies J Autoimmun 10 1997 43 57
40. Casciola-Rosen L.A. Anhalt G. Rosen A. Autoantigens targeted in systemic lupus erythernatosus are clustered in two populations of surface structures on apoptotic keratinocytes J Exp Med 179 1994 1317 1330
41. Ravirajan C.T. Harmer I. McNally T. Hohmann A. Mackworth-Young C.G. Isenberg D.A. Phospholipid binding specificities and idiotype expression of hybridoma derived monoclonal autoantibodies from splenic cells of patients withsystemic lupus crythematosus Ann Rheum Dis 54 1995 471 476
42. Topfer F. Gordon T. McCluskey J. Intra- and intermolecular spreading of autoimmunity involving the nuclear self-antigens LA(SSB) and Ro (SSA) Proc Natl Acad Sci U S A 92 1995 875 879
43. Casciola-Rosen L.A. Miller D.K. Anhalt G.J. Rosen A. Specific cleavage of the 70kD protein component of the Ul small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic celldeath J Biol Chem 269 1994 30757 30760
44. Buttke T.A. Sandstrom P.A. Oxidative stress as a mediator of apoptosis Immunol Today 15 1994 7 10
45. Jacobson D.J. Reactive oxygen species and programmed cell death Trends Biochem Sci 21 1996 83 86
46. Cross A.R. Jones O.T.G. Enzymatic mechanism of superoxide production Biochim Biophys Acta 1057 1991 281 298
47. Hokko S. Miller E. Dudl E. Antiphospholipid antibodies are directed against epitopes of oxidized pbospholipids J Clin Invest 98 1996 815 825
48. Harris E.N. Pierangeli S. Birch D. Anticardiolipin wet workshop report: Fifth international symposium on antiphospholipid antibodies Am J Clin Pathol 101 1994 616 624
49. Vaarala O. Puurunen M. Lukka M. Affinity-purified anticardiolipin antibodies show heterogeneity in their binding to oxidized low-density lipoprotein Clin Exp Immunol 104 1996 269 274
50. Sambrano G.R. Steinberg D. Recognition of oxidativeiydamaged and apoptotic cells by an oxidized low density lipoprotein receptor on mouse peritoneal macrophages: role of membrane phosphatidylserine Proc Natl Acad Sci U S A 92 1995 1396 1400
51. Dim L. Autuori Lentini A. Oliviero S. Piacentim M. The clearance of apoptotic cells in the liver is mediated by asialoglycoprotein receptor FEBS Lett 296 1992 174 178
52. Dini L. Lentini A. Diez Diez G. Phagocytosis of apoptotic bodies by liver endothelial cells J Cell Sci 108 1995 967 973
53. Savill J.S. Smith J. Sarraf C. Ren Y. Abbot F. Rees A. Glomerular mesangial cells and inflammatory macrophages ingest neutrophils undergoing apoptosis Kidney Int 42 1992 924 936
54. Hall S.E. Savill J.S. Henson P.M. Haslett C. Apoptotic neutrophils are phagocytosed by fibroblasts with participation of the fibroblast vitronectin receptor and involvement of a mannose/fucose-specific lectin J Immunol 153 1994 3218 3227
55. Duvall E. Wyllie A.H. Morris R.G. Macrophage recognition of cells undergoing programmed cell death (apoptosis) Immunology 56 1985 351 358
56. Savill J.S. Dransfield I. Hogg N. Haslett C. Vitronectin receptor-mediated Phagocytosis of cells undergoing apoptosis Nature 342 1990 170 173
57. Savill J.S. Hogg N. Ren Y. Haslett C. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis J Clin Invest 90 1992 1513 1522
58. Flora P.K. Gregory G.D. Recognition of apoptotic cells by human macrophages: inhibition by a monocyte/macrophage specific monoclonal antibody Eur J Immunol 24 1994 2625 2632
59. Kreiger M. Herz J. Structure and function of multiligand lipoprotein receptors: macrophage scavenger receptor and LDL receptor-related protein (LPR) Annu Rev Biochem 63 1994 601 637
60. Sambrano G.R. Parthasarathy S. Steinberg D. Recognition of oxidatively damaged erythrocytes by a macrophage receptor with specificity for oxidized low density lipoprotein Proc Natl Acad Sci U S A 91 1994 3265 3269
61. Ramprasad M.P. Fischer W. Witztum J.L. Sambrano G.R. Quehenberger O. Steinberg D. The 94- to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes isidentical to macrosialin, the mouse homologue of human CD68 Proc Natl Acad Sci U S A 92 1995 9580 9584
62. Polunowsky V.A. Wendt C.H. Ingbar D.H. Peterson M.S. Bitterman P.B. Induction of endothelial cell apoptosis by TNF-alpha: modulation of inhibitors of protein synthesis Exp Cell Res 214 1994 584 594
63. Laster S.M. Wood J.G. Gooding L.R. Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis J Immunol 141 1988 2629 2634
64. Heller R. Kronke M. Tumor necrosis factor receptormediated signalling pathways J Cell Biol 126 1994 5 9
65. Dorner T. Hucko M. Mayer W.J. Trefzer U. Burmester G.R. Hiepe F. Enhanced membrane expression of the 52 kDa Ro(SSA) and La(SSB) antigens by human keratinocytes induced by TNT alpha Ann Rheum Dis 54 1995 904 909
66. Beuder B. van Huffel C. Unravelling function on the TNF ligand and receptor families Science 264 1994 707 710
67. Nagata S. Godstein P. The Fas death factor Science 267 1993 1449 1456
68. De Vries R.R.P. Van Rood J.J. HLA and autoimmunity Cohen I. Perspectives on autoimmunity 1988 CRP Press Boca Raton, Florida
69. 1 mice Lupus 3 1994 241 246
70. Jacob C.O. Lee S.K. Strassmann G. Mutational analysis of TNF-a gene reveals a regulatory role for the 3′-untranslated region in the genetic predisposition to lupus-like autoimmunedisease J Immunol 156 1996 3043 3050
71. 1 mice to β2-Glycoprotein I and cardiolipin J Immunol 156 1996 2631 2641
72. Mohan C. Adams S. Stalik V. Datta S.K. Nucleosome: a major immunogen for pathogenic autoantibody-inducing T cells of lupus J Exp Med 177 1993 1367 1381
73. Bell D.A. Morrison B. Vandenbygaard P. Immunogenic DNA-related factor: nucleosome spontaneously released from normal human lymphoid cells stimulate proliferation and immunoglobulinsynthesis of normal mouse lymphocytes J Clin Invest 85 1990 1487 1496
74. Flynn P.D. Byrne C.D. Baglin T.P. Weissberg P.L. Bennett M.R. Thrombin generation by apoptotic vascular smooth muscle cells Blood 89 1997 4378 4384
75. Del Papa N. Meroni P.L. Tincani A. Harris E.N. Balestrieri G. Zanussi C. Relationship between antiphospholipid and antiendothelial antibodies: further characterization of the reactivity on resting and cytokine-activated endothelial cells Clin Exp Rheumatol 10 1992 37 42
76. Quadros N.P. Roberts Thompson P.J. Gallus A.S. Sera from patients with systemic lupus erythematosus demonstrated enhanced IgG binding to endothelial cells pretreated with tumor necrosis factoralpha Rheumatol Int 15 1995 99 105
77. Ferro D. Pittoni V. Quintarelli C. Coexistence of antiphospholipid antibodies and endothelial perturbation in systemic lupus erythematosus Circulation 95 1997 1425 1432
78. Aupeix K. Toti F. Satta N. Bichoff P. Freyssinet J.M. Oyxsterols induce membrane procoagulant activity in monocyte THP-1 cells Biochem J 314 1996 1027 1033
79. Bombeli T. Karsan A. Tait J.F. Harlan J.M. Apoptofic vascular endothelial cells become procoagulant Blood 89 1997 2429 2442
80. Greeno E.W. Bach R.R. Moldow C.F. Apoptosis is associated with increased cell surface tissue factor procoagulant activity Lab Invest 75 1996 281 289
81. Vermes I. Haanen C. Steffens-Nakken H. Reuteligsperger C. A novel assay for apoptosis-flow cytometric detection of phosphaddylserine expression on early apoptotic cells using fluorescent labelled annexin V J Immunol Methods 184 1995 39 51
82. Reutelingsperger C.P.M. The annexins Lupus 3 1994 213 216
83. Van Heerde W.L. De Groot P.G. Reutelingsperger C.P.M. The complexity of the phospholipid binding protein annexin V Thromb Haemost 73 1995 172 179
84. Sun J. Salem H.H. Bird P. Nuclear and cytoplasmic localization of annexin V FEBS Lett 314 1992 425 429
85. Van Heerde W.L. Sakariassen K.S. Hemker H.C. Sixma J.J. Reutlingsperger C.P. de Groot P.G. Annexin V inhibits the procoagulant activity of matrices of TNF-stimulated endothelium under blood flow conditions Arterioscler Thromb 14 1994 824 830
86. Rand J.H. Wu X.X. Guller S. Reduction of annexin V (placental anticoagulant protein I) on placental villi of women with antiphospholipid antibodies and recurrent spontaneousabortion Am J Obstet Gynecol 171 1994 1566 1572
87. Rand J.H. Wu X.X. Andree H.A.M. Lockwood C.J. Guller S. Scher J. Pregnancy loss in the antiphospholipid-antibody syndrome: a possible thrombogenic mechanism N Engl J Med 337 1997 154 160
88. Van Herde W.L. Poort S. van't Veer C. Reutlingsperger C.P. de Groot P.G. Binding of recombinant annexin V to endothelial cells: effect of annexin V binding on endothelial cell mediated thrombin formation Biochem J 302 1994 305 312
89. Bombeli T. Mueller M. Haerbeli A. Anticoagulant properties of vascular endothelium Thromb Haemost 77 1997 408 423
90. Romisch J. Schorlemmer U. Fickenscher K. Paques E.P. Heinburger N. Anticoagulant properties of placental protein 4 (annexin V) Thromb Res 60 1990 355 366
91. Van Ryn McKenna J. Merk H. Muller T.H. Buchanan M.R. Eisert W.G. The effects of heparin and annexin V on fibrin accretion after injury in the jugular vein of rabbits Thromb Haemost 69 1993 227 230
92. Chollet P. Malecaze F. Hullin F. Inhibition of intraocular fibrin formation with annexin V Br J Ophthalmol 76 1992 450 452
93. Flaherty M.J. West S. Heimark R.L. Fujikawa K. Tait J.F. Placental anticoagulant protein 1: measurement in extracellular fluids and cells of the hemostatic system J Lab Clin Med 115 1990 174 181
94. Reutelingsperger C.P. van Heerde W.L. Annexin V the regulator of phosphatidylserine-catalized inflammation and coagulation during apoptosis Cell Mol Life Sci 53 1997 527 532
95. Raynal P. Hullin F. Rabag-Thomas J.M.F. Fauvel J. Chap H. Annexin 5 as a potential regulator of annexin 1 phosphorylation by protein kinase C Biochem J 292 1993 759 765
96. Nakamura N. Shidara Y. Kawaguchi N. Lupus anticoagulant autoantibody induces apoptosis in umbilical vein endothelial cells: involvement of annexin V Biochem Biophys Res Commun 205 1994 1488 1493
97. Simantov R. La Sala J.M. Lo S.K. Activation of cultured vascular endothelial cells by antiphospholipid antibodies J Clin Invest 96 1995 2211 2219
98. McNeil H.P. Simpson R.T. Chesterman C.N. Krilis S.A. Antiphospholipid antibodies are directed against a complex antigen that includes a lipid-binding inhibitor of coagulation: beta2-glycoprotein I(apolipoprotein H) Proc Natl Acad Sci U S A 87 1990 4120 4124
99. Polz E. Kostner G.M. The binding of β2-glycoprotein I to human serum lipoproteins: distribution among density fraction FEBS Lett 102 1979 183 186
100. Kandiah D.A. Krilis S.A. Beta2-glycoprotein I Lupus 3 1994 207 213
101. Hunt J.E. Krilis S. The fifth domain of β2-glycoprotein I contains a phospholipid binding site (Cys281–Cys288) and a region recognized by anticardiolipinantibodies J Immunol 152 1994 653 659
102. Sorice M. Circella A. Griggi T. Anticardiolipin and anti-beta2-GPI are two distinct populations of autoanfibodies Thromb Haemost 75 1996 303 308
103. Cabral A.R. Cabiedes J. Alarcon Segovia D. Antibodies to phospholipid-free β2-glycoprotein I in patients with primary antiphospholipid antibody syndrome J Rheumatol 22 1995 1894 1898
104. El Kadi H.S. Keil L.B. De Bari V.A. Analytical and clinical relationship between human IgG antibodies to β2-glycoprotein I and anticardiolipin antibodies J Rheumatol 22 1995 2233 2237
105. Cabiedes J. Cabral A.R. Alarcon Segovia D. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus J Rheumatol 22 1995 1899 1906
106. Matsura E. Igarashi J. Yasuda T. Triplett D.A. Koike T. Anticardiolipin antibodies recognize β2-glycoprotein I structure altered by interacting with an oxygen modified solid phase surface J Exp Med 179 1994 457 462
107. Price B.E. Rauch J. Shia M.A. Anti-phospholipid antibodies bind to apoptotic but not viable thymocytes in a beta2-glycoprotein I-dependent manner J Immunol 157 1996 2201 2208
108. Roubey R.A.S. Maldonado M.A. Byrd S. Comparison of an enzyme-linked immunosorbent assay for antibodies to β2-glycoprotein I and a conventional anticardiolipin immunoassay Arthritis Rheum 39 1996 1606 1607
109. Cabiedes J. Cabral A.R. Alarcon Segovia D. Clinical manifestations of the antiphospholipid syndrome associate more strongly with anti-β2-glycoprotein I antibodies than withantiphospholipid antibodies J Rheumatol 22 1995 1899 1906
110. Matsura E. Igarashi M. Igarashi Y. Molecular definition of human β2-glycoprotein I (β2-GPI) by cDNA cloning and inter-species differences of β2-GPI in alternation of anticardiolipin binding Int Immunol 3 1991 1217 1221
111. Schouboe I. Beta2-glycoprotein I: a plasma inhibitor of the contact activation of the intrinsic coagulation pathway Blood 66 1985 1086 1091
112. Nimpf J. Wurm H. Kostner G.M. Beta2-glycoprotein I (apo H) inhibits the release reaction of human platelets during ATP induced aggregation Atherosclerosis 63 1987 109 114
113. Henry M. Everson B. Ratnoff O. Inhibition of the activation Hageman factor (factor XII) by beta2-glycoproein I J Lab Clin Med 111 1988 519 523
114. Schousboe I. Inositolphospholipid-accelerated activation of prekallikrein by activated factor XII and its inhibition by β2-glycoprotein I Eur J Biochem 176 1988 629 636
115. Mori T. Takeya H. Nishinka J. Gabazza E.C. Suzuki K. βGlycoprotein I modulates the anticoagulant activity of activated protein C on the phospholipid surface Thromb Haemost 75 1996 49 55
116. Chonn A. Semple S.C. Cullis P.R. β2-Glycoprotein I is a major protein associated with very rapidly cleared liposomes in vivo, suggesting a significant role in the immune clearance of “non self particles.” J Biol Chem 270 1995 25845 25849
117. Hasunuma Y. Matsuura E. Makita Z. Katahira T. Nishi S. Koike T. Involvement of β2-glycoprotein I and anticardiolipin antibodies in oxidatively modified low-density lipoprotein uptake by macrophages Clin Exp Immunol 107 1997 569 573
118. 2 J Leukoc Biol 52 1992 269 273
119. De Benedetti E. Reber G. Mischer P.A. De Moerlose P. No increase of β2-glycoprotein I levels in patients with antiphospholipid antibodies Thromb Haemost 68 1992 624
120. Ichikawa K. Takamatsu K. Shimizu H. Serum apolipoprotein H levels in systemic lupus erythematosus are not influenced by antiphospholipid antibodies Lupus 1 1992 45 49
121. Galli M. Cortellazzo S. Daldossi M. Barbui T. Increased levels of β2-GPI (aca-cofactor) in patients with lupus anticoagulant Thromb Haemost 67 1992 386
122. McNally T. Mackie I.J. Machin S.J. Isenberg D.A. Increased levels of β2-glycoprotein I antigen and β2-glycoprotein I binding antibodies are associated with a history of thromboembolic complications in patients with SLE and primary antiphosphoiipid syndrome Br J Rheumatol 34 1995 1031 1036
123. Nagata S. Suda T. Fas and Fas ligand: lpr and gld mutations Immunol Today 16 1995 39 43
124. Watanabe-Fukunaga R. Brannan C.I. Copeland N.G. Jenkis N.A. Nagata S. Lymphoproliferation disorder in mice explained by defect in Fas antigen that mediates apoptosis Nature 356 1992 314 317
125. Sobel E.S. Kakkanaiah V.N. Rapoport R.G. Eisenberg R.A. Cohen P.L. The abnormal lpr double-negative T cells fail to proliferate in vivo Clin Immunol Immunopathol 74 1995 177 184
126. Gharavi A.E. Mellors R.C. Elkon K.B. IgG anticardiolipin antibodies in murine lupus Clin Exp Immunol 78 1989 233 238
127. Murphy E.D. Roths J.B. Autoimmunity and lymphoproliferation: induction by gene lpr and acceleration by a maleassociated factor in strain BXSB mice Rose N.R. Genetic control of autoimmune disease 1978 Elsevier/North Holland Amsterdam
128. Smith H.R. Hansen C.L. Rose R. Canoso R.T. Autoimmune MRL-lpr/lpr mice are an animal model for the secondary antiphosphoiipid syndrome J Rheumatol 17 1990 911 915
129. Accini A. Dixon F.J. Degenerative vascular disease and myocardial infarction in mice with lupus-like syndrome Am J Pathol 96 1979 477 492
130. Alexander E.L. Moyer C. Travlos G.S. Roths J.B. Murphy E.D. Two histopathologic types of inflammatory vascular disease in MRL/MP autoimmune mice Arthritis Rheum 28 1985 1146 1155
131. Cheng J. Zhou T. Liu C. Protection from Fasmediated apoptosis by a soluble form of the Fas molecule Science 263 1994 1759 1762
132. Rose L.M. Latchman D.S. Isenberg D.A. Elevate soluble Fas production in SLE correlates with HLA status not with disease Lupus 6 1997 717 722
133. Le Deist F. Emile J.F. Rieux-Laucat F. Clinical immunological and pathological consequences of Fas-deficient conditions Lancet 348 1996 719 723
134. Rieux Lacat F. Le Deist F. Hivroz C. Mutation in Fas associated with human lymphoproliferative syndrome and autoimmunity Science 268 1995 1347 1349
135. Fisher G.H. Rosenberg F.J. Straus S.E. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome Cell 81 1995 935 946
136. Emlen W. Niebur J. Kadera R. Accelerated in vitro apoptosis of lymphocytes from patients with systemic lupus erythematosus J Immunol 152 1994 3685 3692
137. Richardson B.C. Monocyte apoptosis in patients with active lupus Arthritis Rheum 39 1996 1432 1434
138. Ravirajan C.T. Sarraf C.E. Anilkumar T.V. Golding M.C.H. Alison M.R. Isenberg D.A. An analysis of apoptosis in lymphoid organs and lupus disease in murine systemic lupus erythematosus (SLE) Clin Exp Immunol 105 1996 306 312
139. Van Houten N. Budd R.C. Accelerated programmed cell death of MRL-lpr/lpr T lymphocytes J Immunol 149 1992 2513 2517
140. Reap E.A. Leslie D. Abrahams M. Eisenberg R.A. Cohen P.L. Apoptosis abnormalities of splenic lymphocytes in autoimmune lpr and gld mice J Immunol 154 1995 936 943
141. Strasser A. Whittingham S. Vaux D.L. Enforced Bcl-2 expression in B lymphoid cells prolongs antibody response and elicits autoimmune disease Proc Natl Acad Sci U S A 88 1991 8661 8665
142. McDonnell T.J. Deane N. Platt F.M. Bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation Cell 57 1989 79 88
143. McDonnell T.J. Nunez G. Platt F.M. Deregulated bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population Mol Cell Biol 10 1990 1901 1907
144. Aringer M. Wintersberger W. Steiner C.W. High levels of Bcl-2 protein in circulating T lymphocytes, but not B lymphocytes of patients with systemic lupus erythematosus Arthritis Rheum 37 1994 1423 1430
145. Rose L.M. Latchman D.S. Isenberg D.A. Bcl-2 and Fas, molecules which influence apoptosis: a possible role in systemic lupus erythematosus Autoimtramity 17 1994 271 278
146. Rose L.M. Latchman D.S. Isenberg D.A. Apoptosis in peripheral lymphocytes in systemic lupus erythematosus: a review Br J Rheumatol 36 1997 158 163
147. Jacobson M.D. Raff M.C. Programmed-cell-death and Bcl-2 protection in very low oxygen Nature 374 1995 814 816
148. Fabisiak J.P. Kagan V.E. Ritov V.B. Johnson D.E. Lazo J.S. Bcl-2 inhibits selective oxidation and externalization of phosphatidylserine during paraquat-induced apoptosis Am J Physiol 272 1997 675 684
149. Manfredi A.A. Rovere P. Heltai S. Apoptosic cell clearance in systemic lupus erythematosus: role of β2-glycoprotein I Arthritis Rheum 41 1997 215 223